Adial Pharmaceuticals, Inc. – NASDAQ:ADIL

Add to watchlist

$0.367

-0.65

-63.99%

Market closed

Open in about 11 hours

-9.73%

month

-9.73%

quarter

-43.96%

year

Market Cap	6.66M
Enterprise value	3.21M

P/E	-0.62
EV/Sales	N/A
EV/EBITDA	-0.16
Price/Sales	N/A
Price/Book	2.13
PEG ratio	N/A
EPS	-5.90

Revenue	N/A
EBITDA	-6.46M
Income	-8.69M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL): Profit margin
Jun 2023	0	1.08M
Sep 2023	0	-1.38M
Dec 2023	32.24K	-1.92M	-5955.26%
Mar 2024	0	-6.47M

Adial Pharmaceuticals Financials Estimate

Q Y

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL): Analyst Estimates
Sep 2025	0	-515.66K
Oct 2025	0	-1.09M
Dec 2025	0	-459.62K
Dec 2025	0	-1.09M

Analysts Price target
Financials & Ratios estimates

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL): Debt to assets
Jun 2023	3778943	461.75K	12.22%
Sep 2023	2867437	528.17K	18.42%
Dec 2023	4737042	653.51K	13.8%
Mar 2024	6684381	562.73K	8.42%

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL): Cash Flow
Jun 2023	-1.89M	800K	58
Sep 2023	-1.39M	350K	138.66K
Dec 2023	-1.22M	350K	3.38M
Mar 2024	-1.62M	0	3.82M

Adial Pharmaceuticals alternative data

Adial Pharmaceuticals
Employees

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL): Employee count
Aug 2023	16
Sep 2023	16
Oct 2023	16
Nov 2023	16
Dec 2023	16
Jan 2024	16
Feb 2024	16
Mar 2024	16
Apr 2024	16
May 2024	4
Jun 2024	4
Jul 2024	4

Adial Pharmaceuticals
Hedge Funds Holdings Q1 2023

6.97% +0.64%

of ADIL is owned by hedge funds

12 -8

hedge funds hold ADIL stock

1.74M +117.90K

shares is hold by hedge funds

ADIL hedge funds holdings changes

Adial Pharmaceuticals
Insider Trading

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL): Insider trades (number of shares)
Period	Buy	Sel
Sep 2023	700	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	29 Sep 2023	SCHUYLER KEVIN director director	Common Stock	700	$2.74	$1,918
Purchase	30 Dec 2021	NEWMAN JAMES W. JR. director director	Common Stock	10,000	$2.71	$27,100
Purchase	30 Dec 2021	NEWMAN JAMES W. JR. director director	Common Stock	5,000	$2.72	$13,600
Purchase	30 Dec 2021	NEWMAN JAMES W. JR. director director	Common Stock	10,000	$2.66	$26,600
Purchase	30 Nov 2021	STILLEY WILLIAM B. III director, 10 perc..	Common Stock	10,600	$2.75	$29,182
Purchase	29 Nov 2021	STILLEY WILLIAM B. III director, 10 perc..	Common Stock	10,000	$2.59	$25,890
Purchase	26 Nov 2021	NEWMAN JAMES W. JR. director director	Common Stock	10,000	$2.85	$28,500
Sale	4 Oct 2021	JOHNSON BANKOLE A. officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	200,000	N/A	N/A
Sale	6 Apr 2021	JOHNSON BANKOLE A. officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	150,000	$2.5	$375,000
Sale	20 Aug 2020	JOHNSON BANKOLE A. officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	350,000	N/A	N/A

ADIL insider trading transactions

Adial Pharmaceuticals
Executives

Insider	Age	Compensation
Mr. William B. Stilley III, M.B.A., MBA (1968) Chairman, Pres & Chief Executive Officer	57	$614,100
Dr. Bankole A. Johnson DSc, Ph.D., M.D., M.Phil, FRCPsych (1960) Founder & Chief Medical Officer	65	$375,000
Mr. Joseph A. M. Truluck M.B.A., MBA (1978) Chief Financial Officer, Treasurer & Sec.	47	$225,030
Dr. Jack W. Reich Ph.D. (1949) Head of Regulatory	76	$17,010

Adial Pharmaceuticals
Latest News

Tuesday, 3 December 2024
08:30	Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations	globenewswire.com
Monday, 25 November 2024
13:01	Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know	zacks.com
Tuesday, 5 November 2024
08:30	Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer	globenewswire.com
Wednesday, 23 October 2024
09:00	Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference	prismmediawire.com
09:00	Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference	globenewswire.com
Thursday, 19 September 2024
08:30	Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder	globenewswire.com
Wednesday, 4 September 2024
09:00	Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference	globenewswire.com
Wednesday, 14 August 2024
08:30	Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update	globenewswire.com
Wednesday, 7 August 2024
09:00	Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder	globenewswire.com
Wednesday, 31 July 2024
08:30	Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044	globenewswire.com
Tuesday, 23 July 2024
12:00	Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?	investorplace.com
08:30	Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder	globenewswire.com
Thursday, 20 June 2024
08:30	Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder	globenewswire.com
Wednesday, 5 June 2024
15:17	Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025	investorplace.com
Wednesday, 29 May 2024
08:30	Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th	globenewswire.com
Wednesday, 15 May 2024
08:30	Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	globenewswire.com
Monday, 22 April 2024
08:30	Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office	globenewswire.com
Wednesday, 10 April 2024
14:15	Adial Pharmaceuticals posts promising update on alcohol disorder drug	Invezz
11:53	Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today?	InvestorPlace
Thursday, 15 February 2024
09:00	Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20	Accesswire
Monday, 30 October 2023
13:32	All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy	Zacks Investment Research
Thursday, 19 October 2023
12:00	Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th	Accesswire
Tuesday, 5 September 2023
08:30	Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference	GlobeNewsWire
Thursday, 1 June 2023
09:00	Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th	GlobeNewsWire
Tuesday, 4 April 2023
11:24	Is Adial Pharmaceuticals (ADIL) Stock Outpacing Its Medical Peers This Year?	Zacks Investment Research
Thursday, 9 March 2023
14:31	10 Hot Penny Stocks Under $1 To Watch This Week	PennyStocks
Wednesday, 19 October 2022
18:10	Forget Bargain Hunting: Play 5 Stocks With Rising P/E	Zacks Investment Research
Thursday, 1 September 2022
11:34	Here's Why Adial Pharmaceuticals, Inc. (ADIL) Could be Great Choice for a Bottom Fisher	Zacks Investment Research
Friday, 26 August 2022
09:02	Forget Bargain Hunting: Play 5 Stocks With Rising P/E	Zacks Investment Research
Monday, 22 August 2022
13:46	Adial Clinical Trial: A Fluff Or A Win?	Seeking Alpha

Ideas & Opinions

Seeking Alpha 22 Aug 2022

Adial Clinical Trial: A Fluff Or A Win?

Frequently Asked Questions (FAQ)

What's the price of Adial Pharmaceuticals stock today?

One share of Adial Pharmaceuticals stock can currently be purchased for approximately $0.37.
When is Adial Pharmaceuticals's next earnings date?

Unfortunately, Adial Pharmaceuticals's (ADIL) next earnings date is currently unknown.
Does Adial Pharmaceuticals pay dividends?

No, Adial Pharmaceuticals does not pay dividends.
How much money does Adial Pharmaceuticals make?

Adial Pharmaceuticals has a market capitalization of 6.66M.
What is Adial Pharmaceuticals's stock symbol?

Adial Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "ADIL".
What is Adial Pharmaceuticals's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Adial Pharmaceuticals?

Shares of Adial Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Adial Pharmaceuticals's key executives?
Adial Pharmaceuticals's management team includes the following people:
- Mr. William B. Stilley III, M.B.A., MBA Chairman, Pres & Chief Executive Officer(age: 57, pay: $614,100)
- Dr. Bankole A. Johnson DSc, Ph.D., M.D., M.Phil, FRCPsych Founder & Chief Medical Officer(age: 65, pay: $375,000)
- Mr. Joseph A. M. Truluck M.B.A., MBA Chief Financial Officer, Treasurer & Sec.(age: 47, pay: $225,030)
- Dr. Jack W. Reich Ph.D. Head of Regulatory(age: 76, pay: $17,010)
Is Adial Pharmaceuticals founder-led company?

Yes, Adial Pharmaceuticals is a company led by its founder Dr. Bankole A. Johnson DSc, Ph.D., M.D., M.Phil, FRCPsych.
How many employees does Adial Pharmaceuticals have?

As Jul 2024, Adial Pharmaceuticals employs 4 workers, which is 75% less then previous quarter.
When Adial Pharmaceuticals went public?

Adial Pharmaceuticals, Inc. is publicly traded company for more then 7 years since IPO on 27 Jul 2018.
What is Adial Pharmaceuticals's official website?

The official website for Adial Pharmaceuticals is adialpharma.com.
Where are Adial Pharmaceuticals's headquarters?

Adial Pharmaceuticals is headquartered at 1180 Seminole Trail, Charlottesville, VA.
How can i contact Adial Pharmaceuticals?

Adial Pharmaceuticals's mailing address is 1180 Seminole Trail, Charlottesville, VA and company can be reached via phone at +43 4422 9800.

Adial Pharmaceuticals, Inc.

adialpharma.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

+43 4422 9800

1180 Seminole Trail
Charlottesville, VA 22901

CIK: 0001513525
ISIN: US00688A2050
CUSIP: 00688A106